The One Treatment Dream: A Promising Breakthrough in Cholesterol Management The latest findings from CRISPR Therapeutics' gene editing therapy have sent shockwaves through the medical community, reviving hopes for a one time solution to high cholesterol and triglycerides.
For decades, statin pills have been the norm for managing these conditions, but this breakthrough raises the prospect of a more lasting, low maintenance treatment.
At its core, CRISPR's therapy attempts to replicate nature's own solution by editing the ANGPTL3 gene, which regulates cholesterol breakdown.